Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation
Status:
Unknown status
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that reducing the duration of clopidogrel therapy from 6 months
to 6 weeks after DES implantation is associated with improved clinical outcomes in patients
on ASA and an oral anticoagulant.